Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Long Tang

Showing results (541-550 of 575) with videos related to

Pageof 58
Sort By:
Radiology|August 26, 2025
MRI-based Middle Neck Involvement in Stage N1-N2 Nasopharyngeal Carcinoma: A Marker for Risk StratificationGuan-Jie Qin, Wei Jiang, Wu-Qi Zhang, et al.
CA: a Cancer Journal for Clinicians|February 19, 2025
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trialLing-Long Tang, Lin Chen, Gui-Qiong Xu, et al.
Nature Communications|May 31, 2022
A lncRNA signature associated with tumor immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinomaYe-Lin Liang, Yuan Zhang, Xi-Rong Tan, et al.
Cancer Cell|July 26, 2024
Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON studyJiawei Lv, Ling-Xin Xu, Zhi-Xuan Li, et al.
ACS Nano|June 13, 2025
Unleashing Electrocatalytic Oxygen Evolution Activity: Engineering Spin States in Strained Correlated Oxides for Enhanced PerformanceShanquan Chen, Feng-Hui Gong, Xiaowen Li, et al.
Microbiome|May 17, 2025
Tissue-resident microbiota signature in nasopharyngeal carcinomaXi-Rong Tan, Han Qiao, Ying-Qing Li, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2017
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trialLei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
JAMA|August 23, 2022
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical TrialLing-Long Tang, Rui Guo, Ning Zhang, et al.
The Lancet. Oncology|December 14, 2011
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trialLei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
Cell Reports. Medicine|February 12, 2025
Advanced image-identified extranodal extension of retropharyngeal lymph nodes in the refinement of N classification for nasopharyngeal carcinomaWei Jiang, Gao-Yuan Wang, Guan-Jie Qin, et al.
Pageof 58

Showing results (541-550 of 575) with videos related to

Sort By:
Pageof 58
Radiology|August 26, 2025
MRI-based Middle Neck Involvement in Stage N1-N2 Nasopharyngeal Carcinoma: A Marker for Risk StratificationGuan-Jie Qin, Wei Jiang, Wu-Qi Zhang, et al.
CA: a Cancer Journal for Clinicians|February 19, 2025
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trialLing-Long Tang, Lin Chen, Gui-Qiong Xu, et al.
Nature Communications|May 31, 2022
A lncRNA signature associated with tumor immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinomaYe-Lin Liang, Yuan Zhang, Xi-Rong Tan, et al.
Cancer Cell|July 26, 2024
Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON studyJiawei Lv, Ling-Xin Xu, Zhi-Xuan Li, et al.
ACS Nano|June 13, 2025
Unleashing Electrocatalytic Oxygen Evolution Activity: Engineering Spin States in Strained Correlated Oxides for Enhanced PerformanceShanquan Chen, Feng-Hui Gong, Xiaowen Li, et al.
Microbiome|May 17, 2025
Tissue-resident microbiota signature in nasopharyngeal carcinomaXi-Rong Tan, Han Qiao, Ying-Qing Li, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2017
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trialLei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
JAMA|August 23, 2022
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical TrialLing-Long Tang, Rui Guo, Ning Zhang, et al.
The Lancet. Oncology|December 14, 2011
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trialLei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
Cell Reports. Medicine|February 12, 2025
Advanced image-identified extranodal extension of retropharyngeal lymph nodes in the refinement of N classification for nasopharyngeal carcinomaWei Jiang, Gao-Yuan Wang, Guan-Jie Qin, et al.
Pageof 58